2025-04-02T08:41:31-05:00 2024-12-31 621114363 HENDERSON HUTCHERSON & MCCULLOUGH PLLC 1755 KIRBY PARKWAY SUITE 200 MEMPHIS TN 38120 990 2024-01-01 471358542 THE UNIVERSITY OF TENNESSEEWEST INSTITUTE FOR CANCER RESEARCH WEST 9013362228 161 CHEROKEE DR MEMPHIS TN 381112600 DR MICHAEL UGWUEKE ACTING PRESIDENT 9013222984 2025-04-01 1 0 RICHARD L WEBB CPA P00362093 9016834234 2025-04-01 2024 2025-03-06 01:10:19Z DR MICHAEL UGWUEKE 1211 UNION AVE STE 700 MEMPHIS TN 38104 269403 0 X WWW.UTWESTINSTITUTE.ORG X 2014 TN THE MISSION OF THE UNIVERSITY OF TENNESSEE/WEST INSTITUTE FOR CANCER RESEARCH (THE "INSTITUTE") IS TO INVEST IN DISCOVERY, INNOVATION AND ADVANCEMENT IN THE FIELD OF ADULT CANCER RESEARCH AND PATIENT EDUCATION, CARE AND SUPPORT AND TO ENSURE THAT ALL ADULT CANCER PATIENTS HAVE ACCESS TO THE MOST INNOVATIVE RESEARCH AND EFFECTIVE THERAPIES TO DEFEAT CANCER IN ITS ENTIRETY WHILE RESPECTING INDIVIDUAL QUALITY OF LIFE. SEE SCHEDULE O FOR ADDITIONAL INFORMATION. 7 7 0 0 0 0 0 0 0 0 419054 269403 0 0 419054 269403 0 0 0 0 0 0 0 0 0 45111 50709 45111 50709 373943 218694 5237953 5464323 34074 24930 5203879 5439393 AT INCEPTION, THE PURPOSE OF THE INSTITUTE WAS TO INVEST IN DISCOVERY, INNOVATION AND ADVANCEMENT IN THE FIELD OF ADULT CANCER RESEARCH AND PATIENT EDUCATION, CARE AND SUPPORT. SEE SCHEDULE O FOR ADDITIONAL INFORMATION. 0 0 THE UNIVERSITY OF TENNESSEE/WEST INSTITUTE FOR CANCER RESEARCH WAS FULLY DEDICATED TO RAISING FUNDS FOR ADULT CANCER RESEARCH IN MEMPHIS, TENNESSEE. THE PLAN WAS TO BROADEN CUTTING-EDGE RESEARCH PROGRAMS AND TO STRENGTHEN THE ABILITY TO PROVIDE THE BEST POSSIBLE CANCER TREATMENT AND SUPPORTIVE SERVICES TO PATIENTS. AS DISCLOSED IN SCHEDULE O, THE ORGANIZATION APPROVED A PLAN OF DISSOLUTION ON OCTOBER 14, 2020. ACCORDINGLY, DURING 2024 THERE WERE NO PROGRAM EXPENSES INCURRED. THE ORGANIZATION DID NOT SOLICIT NOR ACCEPT ANY CONTRIBUTIONS IN 2024. 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 7 7 1 0 0 0 0 1 1 0 1 0 0 1 1 1 1 1 1 0 0 0 TN X THE ORGANIZATION 9013362228 161 CHEROKEE DR MEMPHIS TN 381112600 DR MICHAEL UGWUEKE PRESIDENT 1.00 X X 0 0 0 DR NEIL HAYES DIRECTOR 1.00 X 0 0 0 MONICA WHARTON DIRECTOR 1.00 X 0 0 0 DR DAVID SHIBATA SECRETARY 1.00 X X 0 0 0 DR BRADLEY SOMER DIRECTOR 1.00 X 0 0 0 DR KURT TAUER DIRECTOR 1.00 X 0 0 0 DR TODD TILLMANNS DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 0 269403 269403 269403 0 0 269403 X 20000 20000 5636 5636 16325 16325 5081 5081 1237 1237 STORAGE 2430 2430 50709 0 50709 0 102249 58722 5014166 5273362 121538 132239 5237953 5464323 34074 24930 34074 24930 X 4445072 4680586 758807 758807 5203879 5439393 5237953 5464323 218694 16820 0 X 0 0 0 X 55267 4546 59813 55267 4546 59813 59813 51013 219391 289703 419054 269403 1248564 1308377 0.04570 0.51040 X FORM 990 - EXPLANATION ON OCTOBER 14, 2020, THE BOARD OF DIRECTORS ADOPTED A PLAN OF DISSOLUTION FOR THE ORGANIZATION. THE PLAN OF DISSOLUTION WAS PROVIDED TO THE STATE OF TENNESSEE ATTORNEY GENERAL AS REQUIRED BY TENNESSEE CODE ANNOTATED SECTION 48-64-103. ON FEBRUARY 14, 2022, THE ATTORNEY GENERAL ("AG")OF TENNESSEE ADVISED, UPON REVIEW OF THE PLAN OF DISSOLUTION, NO ACTION WOULD BE TAKEN BY THE AG'S OFFICE. THE ORGANIZATION IS IN THE PROCESS OF FINALIZING THE DISSOLUTION AND EXPECTS TO COMPLETE DISSOLUTION DURING 2025 AND WILL INFORM THE AG WHEN COMPLETED IN ACCORDANCE WITH THE STATUTE. FORM 990, PART VI, SECTION A, LINE 2 THE CURRENT VOTING MEMBERS OF THE INSTITUTE'S BOARD HAVE A BUSINESS RELATIONSHIP AS THE AFOREMENTIONED VOTING MEMBERS ARE OWNERS, OFFICERS OR EMPLOYEES UNDER THEIR RELATED ENTITY AS FOLLOWS: WEST CLINIC, PLLC DR. BRADLEY G. SOMER DR. KURT W. TAUER DR. TODD TILLMANNS METHODIST LEBONHEUR HEALTHCARE DR. MICHAEL UGWUEKE MONICA WHARTON UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER DR. DAVID SHIBATA DR. NEIL HAYES THE OCTOBER 14, 2020, ACTION BY DIRECTORS APPOINTED THREE BOARD MEMBERS, DR. FORBES, DR. STROME , AND DR. TILLMANNS, AS MEMBERS OF THE DISSOLUTION COMMITTEE, AND GAVE THEM PLENARY AUTHORITY TO WIND DOWN THE AFFAIRS OF THE INSTITUTE THROUGH ITS COMPLETE LIQUIDATION PER THE PLAN OF DISSOLUTION. DRS. FORBES AND STROME LEFT THEIR RESPECTIVE ORGANIZATIONS IN 2023; ACCORDINGLY, MONICA WHARTON AND DR. DAVID SHIBATA REPLACED THEM AS MEMBERS OF THE DISSOLUTION COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A ELECTION OF MEMBERS AND THEIR RIGHTS TO THE BOARD OF THE INSTITUTE ARE APPOINTED EQUALLY BY METHODIST LEBONHEUR HEALTHCARE, UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER, AND WEST CLINIC, PLLC. FORM 990, PART VI, SECTION A, LINE 7B THE BOARD OF DIRECTORS ELECTED A DISSOLUTION COMMITTEE TO HANDLE ACTIVITIES, GOVERNANCE AND OPERATIONS OF THE INSTITUTE AS DESCRIBED IN SCHEDULE O, EXPLANATION. FORM 990, PART VI, SECTION A, LINE 8A AS DESCRIBED IN SECTION O, THE BOARD OF DIRECTORS ELECTED A DISSOLUTION COMMITTEE TO HANDLE ALL OF THE ACTIVITIES OF THE ORGANIZATION INCLUDING GOVERNANCE AND OPERATIONS. THE BOARD MET IN 2023, BUT DID NOT MEET IN 2024. THE DISSOLUTION COMMITTEE MET IN 2024 AND FORMAL MINUTES WERE MAINTAINED. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS ELECTED A DISSOLUTION COMMITTEE TO HANDLE ACTIVITIES, GOVERNANCE AND OPERATIONS OF THE INSTITUTE FOR 2024. THE DISSOLUTION COMMITTEE WILL REVIEW AND PROVIDE COMMENTS OR SUGGESTED CHANGES AND APPROVE THE FORM 990 BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C POLICIES ADOPTED BY THE ORGANIZATION PRIOR TO THE INITIATION OF THE DISSOLUTION PROCESS, REQUIRE ANNUAL DISCLOSURE FORMS FOR ANY POTENTIAL CONFLICTS OF INTEREST FROM ALL BOARD MEMBERS. AS DISCLOSED IN SCHEDULE O, THE ORGANIZATION'S DISSOLUTION COMMITTEE IS RESPONSIBLE FOR GOVERNANCE AND OPERATIONS. THE DISSOLUTION COMMITTEE IS AWARE OF THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION B, LINE 15 DURING THE YEAR ENDED 2024, THE ORGANIZATION HAD NO EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE INSTITUTE HAS ALL OF THE REQUIRED PUBLIC DISCLOSURE DOCUMENTS, INCLUDING FORMS 990 AND 1023 AND THE INTERNAL REVENUE SERVICE LETTER VERIFYING THE APPROVAL OF THE INSTITUTE'S TAX EXEMPT STATUS IN A SEPARATE BINDER MARKED OPEN FOR PUBLIC INSPECTION. FORM 990 - PART VI, SECTION A, QUESTION 8A THE OCTOBER 14, 2020, ACTION BY DIRECTORS APPOINTED THREE BOARD MEMBERS,. AS OF DECEMBER 31, 2024, DR. SHIBATA, MS. WHARTON AND DR TILLMANNS ARE THE MEMBERS OF THE DISSOLUTION COMMITTEE WITH AUTHORITY TO COMPLETE THE LIQUIDATION OF THE ORGANIZATION PER THE PLAN OF DISSOLUTION. THEREFORE, THE FULL BOARD IS NO LONGER TAKING AN ACTIVE PART WITH RESPECT TO THE INSTITUTE'S DISSOLUTION AND TERMINATION ACTIVITIES. THE DISSOLUTION COMMITTEE DID MAINTAIN MINUTES OF ALL MEETINGS. FORM 990, PART IX, LINE 11G BOOKKEEPING FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 5,081. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,081.